GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Adhera Therapeutics ATRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Adhera Therapeutics — daily ATRX Delayed
Market value
$231
Last close × shares
Volume
84k
Shares, 30 Oct 2026

About Adhera Therapeutics

Its shares trade under the ticker ATRX. It has been listed since 15 April 1994. In the fiscal year to 31 December 2020, it reported revenue of $132,000 and a net loss of $3.8m. At that date it held total assets of $1,000 and shareholders' equity of −$14.8m.

Adhera Therapeutics, Inc. engages in the discovery, development, and commercialization of drug therapeutics for hypertension. The company is headquartered in Wake Forest, North Carolina. The firm develops and commercializes pharmaceutical therapies and provides technology to improve patient outcomes. The company is also focused on developing and commercializing late-stage, non-addictive pain therapeutics. The company provides Celecoxib-Lisinopril fixed dose combination (IT-102) and Celecoxib-Olmesartan fixed dose combination (IT-103), which are designed to control the side-effect of edema that prohibits the drug from being prescribed at higher doses. IT-102 targets a population requiring angiotensin converting enzyme (ACE) inhibitors, such as lisinopril and IT-103 targets a population requiring olmesartan. The firm is also focused on commercializing perindopril arginine and amlodipine besylate (PRESTALIA) through DyrctAxess, which is a patient-centric treatment platform.

Figures and description from our data supplier, not checked against the company's own report.

More about Adhera Therapeutics →

Latest on Adhera Therapeutics

Our reporting

We have not reported on Adhera Therapeutics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Adhera Therapeutics's ticker?

Adhera Therapeutics trades as ATRX on its US listing, under ISIN US00687E4061.

What was Adhera Therapeutics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.